461 related articles for article (PubMed ID: 30474535)
1. Polymyxin Resistance Mechanisms: From Intrinsic Resistance to Mcr Genes.
Meletis G; Skoura L
Recent Pat Antiinfect Drug Discov; 2018; 13(3):198-206. PubMed ID: 30474535
[TBL] [Abstract][Full Text] [Related]
2. Resistance to polymyxins in Gram-negative organisms.
Jeannot K; Bolard A; Plésiat P
Int J Antimicrob Agents; 2017 May; 49(5):526-535. PubMed ID: 28163137
[TBL] [Abstract][Full Text] [Related]
3. Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and
Chew KL; La MV; Lin RTP; Teo JWP
J Clin Microbiol; 2017 Sep; 55(9):2609-2616. PubMed ID: 28592552
[TBL] [Abstract][Full Text] [Related]
4. Polymyxin Combinations Combat
Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of EDTA and Dipicolinic Acid in Broth Microdilution with Polymyxin B as a Phenotypic Test to Detect the
Wink PL; Caierão J; Nunes AGA; Collar GDS; Martins JB; Dalmolin TV; Pilonetto M; Barth AL
Microb Drug Resist; 2020 Apr; 26(4):329-333. PubMed ID: 31592718
[TBL] [Abstract][Full Text] [Related]
6. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
Ardebili A; Izanloo A; Rastegar M
Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
[TBL] [Abstract][Full Text] [Related]
7. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
[TBL] [Abstract][Full Text] [Related]
8. Polymyxin B: similarities to and differences from colistin (polymyxin E).
Kwa A; Kasiakou SK; Tam VH; Falagas ME
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915
[TBL] [Abstract][Full Text] [Related]
9. Colistin and polymyxin B in critical care.
Michalopoulos A; Falagas ME
Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
Doymaz MZ; Karaaslan E
Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
[No Abstract] [Full Text] [Related]
11. Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.
Ezadi F; Ardebili A; Mirnejad R
J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30541939
[TBL] [Abstract][Full Text] [Related]
12. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
13. Towards Understanding MCR-like Colistin Resistance.
Sun J; Zhang H; Liu YH; Feng Y
Trends Microbiol; 2018 Sep; 26(9):794-808. PubMed ID: 29525421
[TBL] [Abstract][Full Text] [Related]
14. Performances of the Rapid Polymyxin
Lescat M; Poirel L; Jayol A; Nordmann P
Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
[No Abstract] [Full Text] [Related]
15. Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis.
De Oliveira DMP; Bohlmann L; Conroy T; Jen FE; Everest-Dass A; Hansford KA; Bolisetti R; El-Deeb IM; Forde BM; Phan MD; Lacey JA; Tan A; Rivera-Hernandez T; Brouwer S; Keller N; Kidd TJ; Cork AJ; Bauer MJ; Cook GM; Davies MR; Beatson SA; Paterson DL; McEwan AG; Li J; Schembri MA; Blaskovich MAT; Jennings MP; McDevitt CA; von Itzstein M; Walker MJ
Sci Transl Med; 2020 Nov; 12(570):. PubMed ID: 33208501
[TBL] [Abstract][Full Text] [Related]
16. Deep Mutational Scanning Reveals the Active-Site Sequence Requirements for the Colistin Antibiotic Resistance Enzyme MCR-1.
Sun Z; Palzkill T
mBio; 2021 Dec; 12(6):e0277621. PubMed ID: 34781730
[TBL] [Abstract][Full Text] [Related]
17. Recent progress on elucidating the molecular mechanism of plasmid-mediated colistin resistance and drug design.
Kai J; Wang S
Int Microbiol; 2020 Aug; 23(3):355-366. PubMed ID: 31872322
[TBL] [Abstract][Full Text] [Related]
18. Rational use of intravenous polymyxin B and colistin: A review.
Zakuan ZD; Suresh K
Med J Malaysia; 2018 Oct; 73(5):351-359. PubMed ID: 30350826
[TBL] [Abstract][Full Text] [Related]
19. Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.
Jones RN; Anderegg TR; Swenson JM;
J Clin Microbiol; 2005 Feb; 43(2):925-7. PubMed ID: 15695708
[TBL] [Abstract][Full Text] [Related]
20. Genomic Characterization of Nonclonal mcr-1-Positive Multidrug-Resistant Klebsiella pneumoniae from Clinical Samples in Thailand.
Srijan A; Margulieux KR; Ruekit S; Snesrud E; Maybank R; Serichantalergs O; Kormanee R; Sukhchat P; Sriyabhaya J; Hinkle M; Crawford JM; McGann P; Swierczewski BE
Microb Drug Resist; 2018 May; 24(4):403-410. PubMed ID: 29688801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
